Deze pagina is automatisch vertaald en de nauwkeurigheid van de vertaling kan niet worden gegarandeerd. Raadpleeg de Engelse versie voor een brontekst.

Thumb Muscle Activation During First Dorsal Interosseous Activities of Daily Living in Thumb Base Osteoarthritis

21 juni 2026 bijgewerkt door: carmen menaya fernandez, University of Malaga

A Between-Group Comparison of First Dorsal Interosseous and Abductor Pollicis Longus Muscle Activation During First Dorsal Interosseous Activities of Daily Living in Individuals With and Without Thumb Base Osteoarthritis

The aim of this study is to investigate whether there are differences in muscle activation of the First Dorsal Interosseous (FDI) and the Abductor Pollicis Longus (APL) between individuals with and without trapeziometacarpal osteoarthritis (TMC OA) of the thumb during the performance of six activities of daily living (ADLs).

The FDI has been defined as a key stabilizer of the TMC joint of the thumb. However, the literature reports limited information on FDI and APL activation during ADLs. TMC OA of the thumb can cause pain, decreased thumb strength, impaired hand function, and difficulty performing ADLs. Understanding muscle activation patterns during these activities is essential to comprehend how this condition affects hand function and to guide more specific and effective rehabilitation strategies.

Participants will perform six ADLs: turning a key to open, turning a key to close, picking up a coin, writing, squeezing a tube of toothpaste, and holding a glass of water. Muscle activity will be recorded using surface electromyography (sEMG) during all tasks.

Adults aged 30 years and older, both men and women, with TMC osteoarthritis and healthy controls without osteoarthritis will be invited to participate.

Researchers will measure the activation patterns of the FDI and APL muscles during the ADLs, with the aim of identifying differences between both groups and providing evidence to guide the rehabilitation of patients with thumb base osteoarthritis.

Studie Overzicht

Toestand

Nog niet aan het werven

Gedetailleerde beschrijving

Trapeziometacarpal osteoarthritis (OA TMC) of the thumb is a chronic and progressive degenerative disease characterized by loss of articular cartilage, subchondral sclerosis, capsuloligamentous laxity, and osteophyte formation in the first metacarpal. Patients typically present with pain and muscle weakness, which impair hand function and limit activities of daily living (ADLs), resulting in a considerable personal and social burden, including reduced quality of life and work disability. Previous studies have highlighted the clinical importance of thumb TMC joint stabilizers. Research has demonstrated that the first dorsal interosseous (FDI) functions as the main stabilizer of the TMC joint, whereas the abductor pollicis longus (APL) acts as a primary destabilizer. These findings suggest that rehabilitation programs should focus on strengthening the FDI to improve joint stability. However, despite the clinical importance of targeting these muscles, the literature reports limited information on how the FDI and APL behave during activities of daily living.

The aim of this study is to investigate whether there are differences in muscle activation of the FDI and APL between individuals with and without thumb OA TMC during the performance of six activities of daily living, in order to inform rehabilitation strategies. Adequate rehabilitation is essential for maintaining muscle function, slowing the progression of joint degeneration, and improving hand performance, yet it remains unclear how these muscles are engaged during functional daily tasks.

This is a cross-sectional observational comparative study with both within-subject and between-group analyses. The study includes two groups: adults aged 30 years and older, both men and women, with a clinical diagnosis of OA TMC and healthy controls without musculoskeletal or neurological disorders affecting the hand. Exclusion criteria include sensory disturbances such as numbness or tingling, cardiac pacemaker implantation, upper limb entrapment neuropathies or cervical radiculopathy, neuromuscular diseases, systemic conditions including diabetes or hypothyroidism, history of cancer, rheumatoid arthritis, anticoagulation therapy, chemotherapy, exposure to neurotoxins, or recent upper limb trauma or surgery.

Surface electromyography (sEMG) is used to record muscle activity of the FDI and APL. Skin is prepared by shaving if necessary and cleaning with alcohol to reduce impedance and ensure optimal adherence of surface electrodes. Bipolar surface electrodes with a diameter of 20 millimeters and an inter-electrode distance of 20 millimeters are placed according to SENIAM guidelines. For the FDI, electrodes are positioned over the dorsal belly of the muscle aligned with fiber direction, with one electrode in the distal ulnar region between the first and second metacarpals. For the APL, electrodes are placed approximately five centimeters distal to the wrist, medial to the radius, longitudinally aligned and transversely away from adjacent muscles. Electrode placement is verified by palpation and selective activation tasks.

Participants perform six standardized tasks simulating ADLs: turning a key toward the ulnar side, turning a key toward the radial side, picking up a coin, writing a word with a pen, squeezing a full tube of toothpaste, and holding a glass of water while performing a drinking gesture. Each task is performed in three consecutive three-second isometric repetitions with a thirty-second rest between repetitions to minimize fatigue.

It is hypothesized that individuals with thumb TMC osteoarthritis will demonstrate altered activation patterns of the FDI and APL compared with healthy controls, and that specific functional tasks will elicit greater FDI activation, supporting targeted interventions to enhance joint stability and hand function in patients with thumb base osteoarthritis.

Studietype

Observationeel

Inschrijving (Geschat)

50

Contacten en locaties

In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.

Studiecontact

  • Naam: CARMEN MENAYA FERNANDEZ, Doctoral Student
  • Telefoonnummer: +34658424375
  • E-mail: cmenayaf@gmail.com

Studie Locaties

    • Málaga
      • Málaga, Málaga, Spanje, 29071
        • Universidad de Málaga

Deelname Criteria

Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.

Geschiktheidscriteria

Leeftijden die in aanmerking komen voor studie

  • Volwassen
  • Oudere volwassene

Accepteert gezonde vrijwilligers

Ja

Bemonsteringsmethode

Niet-waarschijnlijkheidssteekproef

Studie Bevolking

The study population will include adults aged 30 years and older, both men and women, divided into two groups. The first group will consist of individuals with a clinical diagnosis of thumb trapeziometacarpal osteoarthritis, and the second group will consist of healthy controls without musculoskeletal or neurological disorders affecting the hand.

Beschrijving

Inclusion criteria for the TMC OA group:

- Clinical diagnosis of thumb TMC osteoarthritis.

Inclusion criteria for the healthy group:

- Participants with no history of musculoskeletal or neurological disorders affecting the dominant hand were included.

Exclusion Criteria :

  • Presence of numbness, tingling, or other sensory disturbances
  • Cardiac pacemaker implantation
  • Upper limb entrapment neuropathy or cervical radiculopathy
  • History of neuromuscular disease, polyneuropathy, or plexopathy
  • Systemic diseases such as diabetes, hypothyroidism, or chronic liver or kidney disease
  • History of cancer, rheumatoid arthritis, active anticoagulation therapy, chemotherapy, or exposure to neurotoxins
  • Recent upper limb soft tissue or bone injury (trauma, fracture, or surgery of the arm or neck).

Studie plan

Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.

Hoe is de studie opgezet?

Ontwerpdetails

Wat meet het onderzoek?

Primaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Surface electromyographic amplitude of the First Dorsal Interosseous muscle.
Tijdsspanne: Day 1
Mean surface electromyographic amplitude of the First Dorsal Interosseous muscle recorded during each of the 6 activities of daily living.
Day 1
Surface electromyographic amplitude of the Abductor Pollicis Longus muscle
Tijdsspanne: Day 1
Mean surface electromyographic amplitude of the Abductor Pollicis Longus muscle recorded during each of the 6 activities of daily living
Day 1

Medewerkers en onderzoekers

Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.

Publicaties en nuttige links

De persoon die verantwoordelijk is voor het invoeren van informatie over het onderzoek stelt deze publicaties vrijwillig ter beschikking. Dit kan gaan over alles wat met het onderzoek te maken heeft.

Algemene publicaties

Studie record data

Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.

Bestudeer belangrijke data

Studie start (Geschat)

5 juni 2026

Primaire voltooiing (Geschat)

30 augustus 2026

Studie voltooiing (Geschat)

30 augustus 2026

Studieregistratiedata

Eerst ingediend

29 mei 2026

Eerst ingediend dat voldeed aan de QC-criteria

21 juni 2026

Eerst geplaatst (Werkelijk)

25 juni 2026

Updates van studierecords

Laatste update geplaatst (Werkelijk)

25 juni 2026

Laatste update ingediend die voldeed aan QC-criteria

21 juni 2026

Laatst geverifieerd

1 juni 2026

Meer informatie

Termen gerelateerd aan deze studie

Plan Individuele Deelnemersgegevens (IPD)

Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?

NEE

Informatie over medicijnen en apparaten, studiedocumenten

Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel

Nee

Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct

Nee

Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .

Klinische onderzoeken op Trapeziometacarpale artrose

3
Abonneren